Single cell analysis refers to the study of individual cells at the molecular level. It involves techniques that allow the isolation and characterization of individual cells, which is important in understanding cellular heterogeneity and disease progression. The single cell analysis market has been growing rapidly in recent years, driven by advancements in genomics and proteomics research, and the increasing adoption of single cell analysis techniques in various fields, including oncology, neurology, immunology, and stem cell research.
The single cell analysis market is a rapidly growing segment of the life sciences industry. It refers to the use of various techniques and technologies to study individual cells, rather than a population of cells, in order to gain deeper insights into biological processes and diseases.
The single cell analysis market is driven by the increasing demand for precision medicine and the need to understand the complexities of biological systems at the cellular level. With the advent of next-generation sequencing and other high-throughput technologies, researchers are now able to analyze large numbers of individual cells in a single experiment, providing a more complete and nuanced view of cellular behavior and interactions.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ-ย https://www.alliedmarketresearch.com/request-sample/6553
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ, ๐ซ๐๐ฌ๐ญ๐ซ๐๐ข๐ง๐ญ๐ฌ, ๐๐ง๐ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ:
Rise in demand for single cell analysis and high-end technological advancements coupled with surge in R&D activities in the pharmaceutical and biotechnology industries drive the growth of the global single cell analysis market. At the same time, increase in focus on personalized medicines and growing prevalence of cancer have supplemented the growth even more. On the other hand, high cost of single cell analysis products restrains the growth to some extent. Simultaneously, high growth potential of single cell sequencing is projected to pave the way for lucrative growth opportunities in the industry.
๐๐จ๐ฏ๐ข๐-๐๐ ๐ฌ๐๐๐ง๐๐ซ๐ข๐จ:Governments in almost all countries had increased financing for vaccine development and manufacturing, which in turn gave way to a rise in the usage of single-cell analytic tools for Covid-19 research, thus impacting the global single cell analysis market positively.
A deeper understanding of the host immune response during illness progression is highly essential in order to more precisely fabricate prognostic and diagnostic indicators and initiate proper therapeutic approaches for patients. Researchers can gain a better comprehension of immune cells at the single-cell level and how functional cells put up immune protection by taking recourse to single-cell analysis. These factors have boosted the market growth in several ways.
๐๐๐ญ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐๐๐๐-๐๐ ๐ข๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐ง ๐ญ๐ก๐ ๐๐ข๐ง๐ ๐ฅ๐ ๐๐๐ฅ๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ:ย https://www.alliedmarketresearch.com/request-for-customization/6553?reqfor=covid
๐๐ก๐ ๐๐จ๐ง๐ฌ๐ฎ๐ฆ๐๐๐ฅ๐๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐๐จ๐ฆ๐ข๐ง๐๐ญ๐ ๐๐ฒ ๐๐๐๐:
By product, the consumables segment contributed to around two-thirds of the global single cell analysis market share in 2021, and is expected to lead the trail by 2031. The same segment is also expected to exhibit the fastest CAGR of 17.9% from 2022 to 2031. This is due to high usability of products, frequent purchase of reagents, increase in prevalence of target diseases, and constant need for consumables required for assay.
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐๐ ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ) @ย https://www.alliedmarketresearch.com/checkout-final/8c672d1e2cda838a12041e46b44729c8
๐๐ก๐ ๐ง๐๐ฑ๐ญ ๐ ๐๐ง๐๐ซ๐๐ญ๐ข๐จ๐ง ๐ฌ๐๐ช๐ฎ๐๐ง๐๐ข๐ง๐ (๐๐๐) ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐จ๐ง’๐ฌ ๐ฌ๐ก๐๐ซ๐:
Based on techniques, the Next Generation Sequencing (NGS) segment generated around one-third of the global single cell analysis market revenue in 2021, and is expected to lead the trail by 2031. The same segment would also manifest the fastest CAGR of 18.0% from 2022 to 2031, due to rise in genome mapping programs, increase in applications of next-generation sequencing, surge in healthcare expenditure, and technological advancements in sequencing platforms.
๐๐ก๐ ๐จ๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ซ๐ฎ๐ฅ๐ ๐ญ๐ก๐ ๐ซ๐จ๐จ๐ฌ๐ญ:
By application, the oncology segment garnered more than one-third of the global single cell analysis market share in 2021, and is expected to retain its dominance by 2031. The fact that single cell analysis has proven to be highly effective for prior diagnostics of cancer cells drives the segment growth. The neurology segment, on the other hand, is expected to exhibit the fastest CAGR of 18.8% from 2022 to 2031. This is attributed to increase in the prevalence of neurological disorders.
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐ ๐๐ซ๐ง๐๐ซ๐๐ ๐ญ๐ก๐ ๐ฆ๐๐ฃ๐จ๐ซ ๐ฌ๐ก๐๐ซ๐ ๐ข๐ง ๐๐๐๐:
Based on region, North America held the major share in 2021, generating nearly half of the global single cell analysis market. Rise in the well-established healthcare system, surge in number of geriatric patients, and supportive reimbursement policies in the healthcare system propel the market growth. Europe, on the other hand, would garner the fastest CAGR of 21.6% by 2031. Increase in incidences of cancer and a spike in government funding for single cell analysis research fuel the market growth. The other provinces analyzed throughout the report include Asia-Pacific and LAMEA.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ-ย https://www.alliedmarketresearch.com/purchase-enquiry/6553
๐๐๐ฒ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:
1. Danaher Corporation
2. Becton
3. Merck KGAA
4. QIAGEN N.V.
5. Illumina, Inc.
6. Thermo Fisher Scientific, Inc.
7. BGI Genomics Co.Ltd.
8. Dickinson and Company
9. Agilent Technologies, Inc.,
10. Sartorius AG
11. Takara Holdings inc
12. Oxford Nanopore Technologies.
13. 10x Genomics
14. Bio-Rad Laboratories
15. Berkley Light INC.
16. Dolomite Bio
17. Standard Biotools
18. Diasorin Group
The report analyzes these key players in the global single cell analysis market. These players have incorporated various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in assessing the operating segments, their business performance & product portfolio, and so on.
๐๐๐ ๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐:
โข On the basis of product, the consumables segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
โข On the basis of application, the oncology segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
โข On the basis of technique, the next generation sequencing segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
โข Depending on end user, biotechnology and pharmaceutical companies’ segment is projected to grow at a CAGR of 17.6% during the forecast period.
โข Region-wise, North America garnered the largest revenue share in cell analysis industry in 2021.
Other Trending Reports:
Alzheimerโs Therapeutics Market>>ย https://www.alliedmarketresearch.com/alzheimers-therapeutics-market-A10535
Telepsychiatry Market>>ย https://www.alliedmarketresearch.com/telepsychiatry-market-A10313
Contact:
David Correa
5933 NE Win Sivers Drive#205,
Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:ย https://www.alliedmarketresearch.com
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.